Credit Suisse’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $18K | Hold |
|
|||||
|
2023
Q3 | $13.7K | Sell |
|
|||||
|
2023
Q2 | $25.5K | Sell |
|
|||||
|
2023
Q1 | $299K | Buy |
|
|||||
|
2022
Q4 | $476K | Buy |
|
|||||
|
2022
Q3 | $393K | Buy |
|
|||||
|
2022
Q2 | $388K | Sell |
|
|||||
|
2022
Q1 | $1.21M | Buy |
|
|||||
|
2021
Q4 | $1.65M | Buy |
|
|||||
|
2021
Q3 | $2.28M | Sell |
|
|||||
|
2021
Q2 | $4.9M | Buy |
|
|||||
|
2021
Q1 | $3.94M | Sell |
|
|||||
|
2020
Q4 | $4.06M | Buy |
|
|||||
|
2020
Q3 | $3.41M | Sell |
|
|||||
|
2020
Q2 | $8.39M | Buy |
|
|||||
|
2020
Q1 | $327K | Sell |
|
|||||
|
2019
Q4 | $156K | Sell |
|
|||||
|
2019
Q3 | $174K | Buy |
|
|||||
|
2019
Q2 | $182K | Buy |
|
|||||
|
2019
Q1 | $223K | Buy |
|
|||||
|
2018
Q4 | $190K | Sell |
|
|||||
|
2018
Q3 | $459K | Buy |
|
|||||
|
2018
Q2 | $288K | Sell |
|
|||||
|
2018
Q1 | $455K | Buy |
|
|||||
|
2017
Q4 | $337K | Sell |
|
|||||
|
2017
Q3 | $632K | Buy |
|
|||||
|
2017
Q2 | $502K | Sell |
|
|||||
|
2017
Q1 | $879K | Buy |
|
|||||
|
2016
Q4 | $442K | Sell |
|
|||||
|
2016
Q3 | $763K | Sell |
|
|||||
|
2016
Q2 | $1.02M | Buy |
|
|||||
|
2016
Q1 | $960K | Buy |
|
|||||
|
2015
Q4 | $432K | Sell |
|
|||||
|
2015
Q3 | $974K | Buy |
|
|||||
|
2015
Q2 | $1.21M | Buy |
|
|||||
|
2015
Q1 | $377K | Sell |
|
|||||
|
2014
Q4 | $1.09M | Buy |
|
|||||
|
2014
Q3 | $988K | Buy |
|
|||||
|
2014
Q2 | $949K | Sell |
|
|||||
|
2014
Q1 | $1.22M | Buy |
|
|||||
|
2013
Q4 | $227K | Buy |
|